Shrivastava U, Misra A, Mohan V, Unnikrishnan R, Bachani D
Fortis-C-DOC Hospital for Diabetes, Metabolic Diseases and Endocrinology, B-16, Chirag Enclave, New Delhi, India.
Curr Diabetes Rev. 2017;13(1):65-80. doi: 10.2174/1573399812666160805153328.
Non-communicable diseases (NCDs; including coronary heart disease and type 2 diabetes) are rapidly increasing in India causing nearly 5.8 million deaths per year. Primary reasons for rise in NCDs in India are nutrition and lifestyle transitions. Further, presence of higher body fat, abdominal fat, liver and pancreatic fat and lower lean mass than whites, contribute to heightened metabolic and cardiovascular risk in Asian Indians. Importantly, conversion from pre-diabetes to diabetes occurs more rapidly, and reversion to normal glucose regulation with appropriate lifestyle measures is more difficult in Asian Indians than white population. Huge number of patients with diabetes and with complications increase morbidity, mortality and pose substantial economic burden. It is difficult, though not impossible, to decrease pace of rapidly expanding juggernaut of NCDs in India. Only concerted efforts from multiple stakeholders, consistently sincere efforts and intensely focused attention from health officialdom and clear political will may help counter this increasingly difficult challenge. Finally, all prevention and management approaches should be cost-effective, pragmatic, and focused on children and underprivileged populations.
非传染性疾病(包括冠心病和2型糖尿病)在印度正迅速增加,每年导致近580万人死亡。印度非传染性疾病增加的主要原因是营养和生活方式的转变。此外,与白人相比,亚洲印度人身体脂肪、腹部脂肪、肝脏和胰腺脂肪含量更高,瘦体重更低,这导致他们的代谢和心血管风险增加。重要的是,亚洲印度人从糖尿病前期转变为糖尿病的速度更快,而且通过适当的生活方式措施恢复正常血糖调节比白人更困难。大量糖尿病患者及其并发症增加了发病率、死亡率,并带来了巨大的经济负担。在印度,减缓非传染性疾病迅速蔓延的势头虽非不可能,但却很困难。只有多个利益相关者齐心协力、卫生部门始终真诚努力并高度关注以及明确的政治意愿,才可能有助于应对这一日益严峻的挑战。最后,所有预防和管理方法都应该具有成本效益、切实可行,并关注儿童和弱势群体。